Effects of sex steroid hormones on the expression of somatostatin receptors sst1 and sst5 in goldfish pituitary and forebrain
- PMID: 12915760
- DOI: 10.1159/000071963
Effects of sex steroid hormones on the expression of somatostatin receptors sst1 and sst5 in goldfish pituitary and forebrain
Abstract
In the present paper the effects of estradiol and testosterone on the expression of the types 1 and 5 somatostatin receptors (sst1 and sst5) in the goldfish forebrain and pituitary were investigated. Estradiol increased the sst1 expression in both the forebrain and pituitary in a dose- and time-dependent manner. In addition, estradiol also increased the pituitary expression of sst5. On the other hand, testosterone had no effects on the expression of these receptor subtypes. Mature female goldfish were found to have higher sst1 and sst5 expression in the pituitary, as well as a higher expression of sst1 in the forebrain compared to sexually regressed animals. As estradiol treatment increases serum growth hormone levels in goldfish, these data suggest that sst1 and sst5 receptors are likely not directly involved in this aspect of growth hormone release.
Copyright 2003 S. Karger AG, Basel
Similar articles
-
Homologous and heterologous in vitro regulation of pig pituitary somatostatin receptor subtypes, sst1, sst2 and sst5 mRNA.J Mol Endocrinol. 2004 Apr;32(2):437-48. doi: 10.1677/jme.0.0320437. J Mol Endocrinol. 2004. PMID: 15072550
-
Estradiol reduces pituitary responsiveness to somatostatin (SRIF-14) and down-regulates the expression of somatostatin sst2 receptors in female goldfish pituitary.Gen Comp Endocrinol. 2003 Jun 1;132(1):119-24. doi: 10.1016/s0016-6480(03)00055-8. Gen Comp Endocrinol. 2003. PMID: 12765651
-
Regulation of expression of somatostatin genes by sex steroid hormones in goldfish forebrain.Neuroendocrinology. 2002 Jul;76(1):8-17. doi: 10.1159/000063679. Neuroendocrinology. 2002. PMID: 12097812
-
Genetic abnormalities of somatostatin receptors in pituitary tumors.Mol Cell Endocrinol. 2008 May 14;286(1-2):180-6. doi: 10.1016/j.mce.2007.08.013. Epub 2007 Aug 31. Mol Cell Endocrinol. 2008. PMID: 17913341 Review.
-
[New medical treatments in pituitary adenomas].Ann Endocrinol (Paris). 2008 Sep;69 Suppl 1:S16-28. doi: 10.1016/S0003-4266(08)73964-7. Ann Endocrinol (Paris). 2008. PMID: 18954854 Review. French.
Cited by
-
Pituitary somatostatin receptor signaling.Trends Endocrinol Metab. 2010 Mar;21(3):123-33. doi: 10.1016/j.tem.2009.12.003. Epub 2010 Feb 9. Trends Endocrinol Metab. 2010. PMID: 20149677 Free PMC article. Review.
-
[68 Ga]-DOTATATE PET/MR-based evaluation of physiologic somatostatin receptor 2 expression in the adult pituitary gland as a function of age and sex in a prospective cohort.Pituitary. 2023 Aug;26(4):419-428. doi: 10.1007/s11102-023-01329-0. Epub 2023 Jun 7. Pituitary. 2023. PMID: 37285059
-
Efficacy and tolerability of somatostatin analogues according to gender in patients with neuroendocrine tumors.Rev Endocr Metab Disord. 2024 Apr;25(2):383-398. doi: 10.1007/s11154-023-09858-6. Epub 2023 Dec 5. Rev Endocr Metab Disord. 2024. PMID: 38051470 Review.
-
Estrogens Modulate Somatostatin Receptors Expression and Synergize With the Somatostatin Analog Pasireotide in Prostate Cells.Front Pharmacol. 2019 Feb 15;10:28. doi: 10.3389/fphar.2019.00028. eCollection 2019. Front Pharmacol. 2019. PMID: 30828298 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials